Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;67(4):899-910.
doi: 10.1007/s00280-010-1391-0. Epub 2010 Jul 1.

2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion

Haibin Xi  1 , Metin Kurtoglu, Huaping Liu, Medhi Wangpaichitr, Min You, Xiongfei Liu, Niramol Savaraj, Theodore J Lampidis
Affiliations

2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion

Haibin Xi et al. Cancer Chemother Pharmacol. 2011 Apr.

Abstract

Purpose: The glucose analog and glycolytic inhibitor 2-deoxy-D-glucose (2-DG), which is currently under clinical evaluation for targeting cancer cells, not only blocks glycolysis thereby reducing cellular ATP, but also interferes with N-linked glycosylation, which leads to endoplasmic reticulum (ER) stress and an unfolded protein response (UPR). Both bioenergetic challenge and ER stress have been shown to activate autophagy, a bulk cellular degradation process that plays either a pro- or anti-death role. Here, we investigate which pathway 2-DG interferes with that activates autophagy and the role of this process in modulating 2-DG-induced toxicity.

Methods: Pancreatic cancer cell line 1420, melanoma cell line MDA-MB-435 and breast cancer cell line SKBR3 were used to investigate the relationship between induction by 2-DG treatment of ER stress/UPR, ATP reduction and activation of autophagy. ER stress/UPR (Grp78 and CHOP) and autophagy (LC3B II) markers were assayed by immunoblotting, while ATP levels were measured using the CellTiter-Glo Luminescent Cell Viability Assay. Autophagy was also measured by immunofluorescence utilizing LC3B antibody. Cell death was detected with a Vi-Cell cell viability analyzer using trypan blue exclusion.

Results: In the three different cancer cell lines described earlier, we find that 2-DG upregulates autophagy, increases ER stress and lowers ATP levels. Addition of exogenous mannose reverses 2-DG-induced autophagy and ER stress but does not recover the lowered levels of ATP. Moreover, under anaerobic conditions where 2-DG severely depletes ATP, autophagy is diminished rather than activated, which correlates with lowered levels of the ER stress marker Grp78. Additionally, when autophagy is blocked by siRNA, cell sensitivity to 2-DG is increased corresponding with upregulation of ER stress-mediated apoptosis. Similar increased toxicity is observed with 3-methyladenine, a known autophagy inhibitor. In contrast, rapamycin which enhances autophagy reduces 2-DG-induced toxicity.

Conclusions: Overall, these results indicate that the major mechanism by which 2-DG stimulates autophagy is through ER stress/UPR and not by lowering ATP levels. Furthermore, autophagy plays a protective role against 2-DG-elicited cell death apparently by relieving ER stress. These data suggest that combining autophagy inhibitors with 2-DG may be useful clinically.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement None

Figures

Fig. 1
Fig. 1
2-DG induces ATP reduction, ER stress/UPR and autophagy. 1420 (a), MDA-MB-435 (b) and SKBR3 (c) cells were treated with 2-DG at doses as indicated. Upper panels, intracellular ATP levels were measured after 5 h of drug exposure. Lower panels, immunoblotting was performed to detect levels of Grp78, CHOP and LC3B II after 16 h (1420 and MDA-MB-435) or 24 h (SKBR3) of treatment. β-Actin was used as a loading control. *Bands of LC3B I were not detected by short-time film exposure in 1420 and SKBR3 cells. # P < 0.05 and ##P < 0.01, compared to controls
Fig. 2
Fig. 2
Mannose reverses 2-DG-induced ER stress and autophagy without affecting ATP depletion. a 1420 cells were treated either by 4 mM of 2-DG, 1 mM of mannose (Man) or both in the presence or absence of 4 μg/ml of EST for 16 h. Immunoblotting was performed to detect levels of Grp78, CHOP and LC3B II. b 1420 cells were treated either by 4 mM of 2-DG or 4 mM of 2-DG with 1 mM of Man for 16 h. Endogenous LC3B were detected by fluorescent microscopy using an anti-LC3B antibody. c Intracellular ATP levels were measured after 1420 cells were treated either by 4 mM of 2-DG, 1 mM of Man or both for 5 h. d 1420 cells were treated similarly as depicted in (a) without EST for 6 h. Immunoblotting was performed to detect phosphorylated (serine 79) and total ACC levels. Representative blots of one of two independent experiments are shown. e MDA-MB-435 cells were treated either by 10 mM of 2-DG, 1 mM of Man or both. Upper panel, intracellular levels of ATP were measured after 5 h of drug exposure. Lower panel, immunoblotting was performed to detect levels of Grp78, CHOP and LC3B II 16 h after treatment. *Bands of LC3B I were not detected by short-time film exposure in 1420 and SKBR3 cells. f MDA-MB-435 cells were treated and analyzed similarly as 1420 cells in (b) except that 2-DG was used at a dose of 10 mM. g SKBR3 cells were treated and analyzed similarly as MDA-MB-435 cells in (e) except that immunoblotting was performed 24 h after drug exposure. For immunoblotting analyses in (a, e, g), β-actin was used as a loading control. NS, not significant compared to 2-DG alone-treated samples
Fig. 3
Fig. 3
2-DG induces autophagy in a similar kinetics as tunicamycin. 1420 cells were treated with 4 mM of 2-DG or 1 μg/ml of tunicamycin (TM) in the absence (a) or presence (b) of 4 μg/ml EST. At the indicated times, cells were harvested and immunoblotting was performed to detect levels of Grp78, CHOP and LC3B II. β-Actin was used as a loading control. Blots for TM treatment are from one of two independent experiments
Fig. 4
Fig. 4
Oxamate induces ATP depletion but not autophagy. a Intracellular ATP levels were measured after 1420 cells were treated by 4 mM of 2-DG or different doses of oxamate (OX) as indicated for 5 h. b 1420 cells were treated by 4 mM of 2-DG or different doses of OX as indicated in the presence or absence of 4 μg/ml of EST for 16 h. Immunoblotting was performed to detect levels of Grp78, CHOP and LC3B II. Representative blots of one of two independent experiments are shown. c 1420 cells were treated with 5 mg/ml of OX in the presence or absence of 4 μg/ml EST. At the indicated times, cells were harvested and immunoblotting was performed to detect levels of LC3B II. d 1420 cells were treated by 5 mg/ml OX for 16 h. Endogenous LC3B was detected by fluorescent microscopy using an anti-LC3B antibody. e MDA-MB-435 cells were treated and analyzed similarly as 1420 cells in (a) except that 2-DG was used at a dose of 10 mM. f MDA-MB-435 cells were treated by 10 mM of 2-DG or different doses of OX as indicated for 16 h. Immunoblotting was performed to detect levels of Grp78, CHOP and LC3B II. *Bands of LC3B I were not detected by short-time film exposure in 1420 cells. Representative blots of one of two independent experiments are shown. g MDA-MB-435 cells were treated and analyzed similarly as 1420 cells in (d) except that 2-DG was used at a dose of 10 mM. For immunoblotting analyses in (b, c, f), β-actin was used as a loading control. # P < 0.05, ## P < 0.01 and ### P < 0.001, compared to controls
Fig. 5
Fig. 5
Under anaerobic conditions, 2-DG severely depletes ATP and down-regulates autophagy. a Intracellular ATP levels were measured after 1420 cells were treated either by 4 mM of 2-DG, 0.1 μg/ml of oligomycin (OM) or both for 5 h. b 1420 cells were treated either by 4 mM of 2-DG, 0.1 μg/ml of OM or both in the presence or absence of 4 μg/ml of EST for 16 h. Immunoblotting was performed to detect levels of Grp78 and LC3B II. Representative blots of one of two independent experiments are shown. c 1420 cells were treated by 4 mM of 2-DG in combination with 0.1 μg/ml of OM in the presence or absence of 4 μg/ml EST. At the indicated times, cells were harvested and immunoblotting was performed to detect levels of LC3B II. d 1420 cells were treated by 4 mM of 2-DG in combination with 0.1 μg/ml of OM for 16 h. Endogenous LC3B were detected by fluorescent microscopy using an anti-LC3B antibody. e MDA-MB-435 cells were treated and analyzed similarly as 1420 cells in (a) except that 2-DG was used at a dose of 10 mM. f MDA-MB-435 cells were treated either by 4 mM of 2-DG, 0.1 μg/ml of OM or both for 16 h. Immunoblotting was performed to detect levels of Grp78 and LC3B II. *Bands of LC3B I were not detected by short-time film exposure in 1420 cells. For immunoblotting analyses in (b, c, f), β-actin was used as a loading control. ##P < 0.01, compared to 2-DG alone-treated samples
Fig. 6
Fig. 6
Autophagy protects cancer cells from 2-DG-induced cytotoxicity through relieving ER stress. a, b 1420 (a) and MDA-MB-435 (b) cells were treated with the indicated doses of 2-DG in the presence or absence of 10 mM of 3-methyladenine (3-MA) for 48 h. The percentages of dead cells were analyzed based on trypan blue exclusion. c, d 1420 (c) and SKBR3 (d) cells were treated with the indicated doses of 2-DG in the presence or absence of 0.1 μg/ml of rapamycin (Rap) for 48 h (SKBR3) or 72 h (1420). The percentages of dead cells were analyzed based on trypan blue exclusion. e 1420 cells were transfected with either a siRNA targeting luciferase (siLuc, negative control) or a pool of siRNAs against Atg7 (siAtg7) at 50 nM. Forty-eight hours post-transfection, cells were treated with different doses of 2-DG, and 16 h later, harvested and immunoblotted for expression levels of Atg7, LC3B II, Grp78, CHOP and cleaved caspase 3. β-Actin was used as a loading control. Representative blots of one of two independent experiments are shown. f 1420 cells were transfected as depicted above. Forty-eight hours post-transfection, cells were treated with different doses of 2-DG for another 48 h. The percentages of dead cells were then analyzed based on trypan blue exclusion. Representative results of one of two independent experiments are shown. # P < 0.05 and ## P < 0.01, compared to the corresponding 2-DG alone-treated samples (a, b, c, d) or 2-DG-treated cells transfected with siLuc (f)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wick AN, Drury DR, Nakada HI, Wolfe JB. Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem. 1957;224:963–969. - PubMed
    1. Chen W, Gueron M. The inhibition of bovine heart hexokinase by 2-deoxy-D-glucose-6-phosphate: characterization by 31P NMR and metabolic implications. Biochimie. 1992;74:867–873. - PubMed
    1. Liu H, Hu YP, Savaraj N, Priebe W, Lampidis TJ. Hypersensitization of tumor cells to glycolytic inhibitors. Biochemistry. 2001;40:5542–5547. - PubMed
    1. Liu H, Savaraj N, Priebe W, Lampidis TJ. Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (model C) Biochem Pharmacol. 2002;64:1745–1751. - PubMed
    1. Maher JC, Krishan A, Lampidis TJ. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions. Cancer Chemother Pharmacol. 2004;53:116–122. - PubMed

Publication types

MeSH terms